| Effects of VLCD and Bariatric Surgery in Patients With Type 2 Diabetes (NCT05092399) | University of Nottingham | 2022-07-01 |
| Utilization of MAsS in Patients Undergoing LT for HCC (NCT05184283) | Columbia University | 2022-06-16 |
| Healthy Liver - Healthy Brain (NCT05216796) | University of Texas at Austin | 2022-05-18 |
| Nonalcoholic Fatty Liver Disease in HIV Database (NCT05023044) | Johns Hopkins University | 2022-05-12 |
| Evaluation of Gut Permeability in Patients Affected by Obesity and NAFLD: Influence of Ketogenic Diet. (NCT05477212) | Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis | 2022-04-28 |
| Different Doses of ZED1227 vs. Placebo in NAFLD (NCT05305599) | Dr. Falk Pharma GmbH | 2022-04-19 |
| The Visceral Adiposity Measurement and Observation Study (NCT05383456) | Theratechnologies | 2022-04-18 |
| Prevalence of NAFLD in ACS Patients (NCT05378321) | Ziekenhuis Oost-Limburg | 2022-02-01 |
| Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients (NCT05147090) | The University of Hong Kong | 2022-01-02 |
| Weight Loss Effects of M-health App in Obesity Multidisciplinary Outpatient Clinic (NCT05168072) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2021-12-10 |
| Characterization of the Platelet Inflammatory Response in NAFL and NASH (NCT05128253) | Stefania Basili | 2021-12-06 |
| The Effects of Dihydromiricetin on MASLD (NCT05052515) | University of Athens | 2021-11-01 |
| Fruit and Vegetable Products Enriched With Fibre From Potato Starch With Prebiotic Properties for Children and Youth (NCT05140070) | Children's Memorial Health Institute, Poland | 2021-10-06 |
| Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis (NCT06308757) | University of Bologna | 2021-09-29 |
| Postprandial VLDL-triglyceride Metabolism in Type 2 Diabetes Patients With and Without NAFLD (NCT05044130) | University of Aarhus | 2021-09-14 |
| Probiotic Supplementation IN NAFLD Patients (NCT06074094) | Ain Shams University | 2021-09-12 |
| Vigabatrin and Insulin Sensitivity (NCT04321395) | Washington University School of Medicine | 2021-08-23 |
| Effects of Online App Weight Loss Programs on Liver Health in Obese Adults (NCT05015491) | Noom Inc. | 2021-08-09 |
| MLCT Oil for Fatty Liver - PASS Trial (NCT05217745) | National University Hospital, Singapore | 2021-08-05 |
| Determination of Insulin-stimulated Hepatic Glucose Uptake by PET-CT Measurements (NCT04938544) | Maastricht University Medical Center | 2021-08-01 |
| The Effect of Time-restricted Eating on Liver Metabolism (NCT04997486) | University of California, Davis | 2021-07-20 |
| Human Liver ORganoids as a Model to Study the Development of Non-Alcoholic SteatOhepatitis (NASH) (NCT06856252) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2021-07-01 |
| Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) (NCT04634643) | Yale University | 2021-06-28 |
| Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus (NCT04232293) | Nantes University Hospital | 2021-06-25 |
| THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis) (NCT04925362) | Assistance Publique - Hôpitaux de Paris | 2021-06-01 |
| Low-Calorie Diet in People With Prediabetes/Metabolic Syndrome (NCT04786418) | University of Liverpool | 2021-06-01 |
| Bariatric Endoscopy and NAFLD (NCT04895943) | University Hospital Ostrava | 2021-04-29 |
| Characterization of Visceral Adiposity in HIV Mono-infected Patients With NAFLD (NCT05359471) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2021-04-09 |
| COVID-19 and Nonalcoholic Fatty Liver Disease (NCT04982328) | University Hospital for Infectious Diseases, Croatia | 2021-04-01 |
| Quantitative Ultrasound With Liver Incytes for Evaluation of Non-Alcoholic Fatty Liver Disease (NCT04576923) | Indiana University | 2021-03-19 |
| Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD (NCT04774302) | Clinique Pasteur | 2021-03-18 |
| DDI Study of ASC41 in HV and the PK, Safety and Tolerability in Subjects With NAFLD. (NCT04845646) | Gannex Pharma Co., Ltd. | 2021-03-16 |
| Serum Selenium and Zinc Levels in Non-alcoholic Fatty Liver Disease Patients (NCT04834063) | Sohag University | 2021-03-15 |
| Defining Circadian Metabolism in Non-alcoholic Fatty Liver Disease (NCT05962099) | University of Oxford | 2021-03-01 |
| Economic Burden of NAFLD (NCT05035043) | Hasselt University | 2021-03-01 |
| Chronic Kidney Disease and Non-alcoholic Fatty Liver Diseases (NCT04779905) | Sohag University | 2021-02-28 |
| A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD (NCT04812262) | Neuraly, Inc. | 2021-02-24 |
| Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRE (NCT04591106) | University of California, Los Angeles | 2021-02-17 |
| An Investigator Initiated Prospective, Four Arms Randomized Comparative Study of Efficacy and Safety of Saroglitazar, Vitamin E and Life Style Modification in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)/ Non-alcoholic Steatohepatitis (NASH) (NCT04193982) | Asian Institute of Gastroenterology, India | 2021-01-31 |
| Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL) (NCT04704063) | Yuen Kah Hay | 2021-01-01 |
| Study to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy Volunteers (NCT04692025) | Gannex Pharma Co., Ltd. | 2020-12-27 |
| Study to Evaluate the Safety and Efficacy of ASC41 in Overweight and Obese Subjects (NCT04686994) | Gannex Pharma Co., Ltd. | 2020-12-22 |
| The Influence of Probiotic Supplementation on Depressive Symptoms, Inflammation and Oxidative Stress Parameters and Faecal Microbiota in Patients With Depression Depending on Metabolic Syndrome Comorbidity (NCT04756544) | Medical University of Lodz | 2020-12-17 |
| Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH (NCT04702490) | Metacrine, Inc. | 2020-12-15 |
| The Role of Dietary Carbohydrate and Fat Availability in the Regulation of Hepatic Lipid Content (NCT04581421) | Hvidovre University Hospital | 2020-12-03 |
| Follow-up of NAFLD Patients With MRI-PDFF (NCT04910178) | Asmaa Abdelfattah Elsayed | 2020-12-01 |
| NASH in Subjects With Different Classes of Obesity (NCT04653103) | Catholic University of the Sacred Heart | 2020-11-20 |
| Network Meta-analysis of Intermittent Fasting and Cardiometabolic Risk (NCT05309057) | University of Toronto | 2020-11-01 |
| Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver Disease (NCT05768334) | Helwan University | 2020-11-01 |
| The MULTISITE Study (NCT05699863) | Aalborg University Hospital | 2020-10-06 |
| Bariatric Endoscopy and NAFLD (NCT04669470) | University of Ostrava | 2020-10-01 |
| Whey or Casein - Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow Proteins (NCT04564391) | Charite University, Berlin, Germany | 2020-09-21 |
| The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology (NCT05370053) | University of Kansas Medical Center | 2020-09-01 |
| Impact of Exercise Intervention for Patients With Non-alcoholic Fatty Liver Disease (NCT04463667) | National Taiwan University Hospital | 2020-08-25 |
| Liver Fat as a Dietary Target for Treating Cardiometabolic Disorders in Prediabetes and Type 2 Diabetes (NCT04527965) | Uppsala University | 2020-08-11 |
| Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease (NCT06176079) | Michael Ohliger, MD PhD | 2020-07-22 |
| Study Visceral Adipose Tissue and Liver Stifness in a Retrospective Cohort of Diabetes Mellitus Patients (NCT04493814) | Central Hospital, Nancy, France | 2020-07-01 |
| T1-mapping by Cardiovascular Magnetic Resonance Imaging to Assess Non-Alcoholic Fatty Liver Disease (NCT04220450) | Dr. Andreas Kammerlander | 2020-06-01 |
| The Liver BIoBank Lombardia of Fatty Liver (NCT06566105) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2020-06-01 |
| Effectiveness of Bariatric Surgery for NAFLD/NASH (NCT04366999) | Beijing Friendship Hospital | 2020-04-21 |
| Safety and Tolerability of Novel Medical Nutrition Products for NAFLD Treatment (NCT04308980) | Russian Academy of Medical Sciences | 2020-03-20 |
| Study of NGM395 in Adult Participants (NCT04187339) | NGM Biopharmaceuticals, Inc | 2020-02-13 |
| NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand (RANKL) (NCT03968354) | Assistance Publique - Hôpitaux de Paris | 2020-02-01 |
| Adipokine Genetic Variations in predictingNAFLD Progression to NASH in Egyptian Patients (NCT04561895) | Cairo University | 2020-01-01 |
| The Effect of Consecutive Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease (NAFLD) (NCT04465032) | Leiden University Medical Center | 2019-12-10 |
| Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients (IMPROVE Study) (NCT04146636) | University Hospital, Angers | 2019-12-09 |
| NAFLD in HIV-infected Patients (NCT04215926) | Shanghai Public Health Clinical Center | 2019-12-05 |
| The Role of Bariatric Surgeries in Management of Nonalcoholic Fatty Liver Disease (NCT04127370) | Assiut University | 2019-11-01 |
| Vitamin E for NASH Treatment in HIV Infected Individuals (NCT03669133) | Indiana University | 2019-10-01 |
| LITMUS Imaging Study (NCT05479721) | University of Oxford | 2019-09-04 |
| Validation of the LiverFASt Test and the Associated Fibrosis Staging Scores Compared to Liver Tissue Pathology Via Liver Biopsy (NCT03980912) | Fibronostics USA, Inc | 2019-09-01 |
| Study of the Safety and Tolerability of AXA1957 in Adolescent Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD) (NCT04073407) | Axcella Health, Inc | 2019-07-27 |
| The Study of Lithogenesis Processes in Patients With Non-alcoholic Fatty Liver Disease (NAFLD) (NCT06357052) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2019-07-19 |
| A Phase 2 Study of Elobixibat in Adults With NAFLD or NASH (NCT04006145) | Albireo | 2019-06-06 |
| Comparison of the Effects of Metformin and Pioglitazone on Liver Enzymes and Ultrasound Changes in Non-Diabetic Non-Alcoholic Fatty Liver (NCT05521633) | King Edward Medical University | 2019-06-06 |
| Lifestyle Modification Programme for HIV-infected Individuals With Fatty Liver (NCT03913351) | Chinese University of Hong Kong | 2019-05-21 |
| The Role of Microbiome Reprogramming on Liver Fat Accumulation (NCT03914495) | AdventHealth Translational Research Institute | 2019-05-21 |
| DIAbetes and NAFLD (NCT06315361) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2019-05-20 |
| Treating PCOS With Semaglutide vs Active Lifestyle Intervention (NCT03919929) | University of Colorado, Denver | 2019-05-03 |
| Bariatric Surgery-Induced Shift in Gut Microbiome and NAFLD (NCT04263376) | The Cleveland Clinic | 2019-04-24 |
| Prevalence of NAFLD and Correlation With Its Main Risk Factors Among Egyptian (NCT04081571) | Cairo University | 2019-04-01 |
| NAFLD in Diabetes Type 2 in Primary Care (NCT03864510) | Linkoeping University | 2019-04-01 |
| Prevalence of NAFLD in T2DM Patients (NCT06445335) | Ziekenhuis Oost-Limburg | 2019-03-01 |
| Safety, Tolerability, and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With Nonalcoholic Fatty Liver Disease (NAFLD) (NCT03639623) | Zydus Therapeutics Inc. | 2019-02-25 |
| Genetic-specific Effects of Fructose on Liver Lipogenesis (NCT03783195) | University of North Carolina, Chapel Hill | 2019-01-25 |
| Omega-3 vs Very Low Calorie Diet for Liver Size Reduction (NCT03132662) | McMaster University | 2019-01-01 |
| Fighting Fatty Liver in India (NCT03844165) | University of Nottingham | 2019-01-01 |
| Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD) (NCT04073368) | Axcella Health, Inc | 2018-12-03 |
| Splanchnic and Systemic VLDL-TG and FFA Balance (NCT04292977) | University of Aarhus | 2018-12-01 |
| A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk Populations (NCT03726827) | Fatty liver Foundation | 2018-12-01 |
| A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM) (NCT03656744) | HighTide Biopharma Pty Ltd | 2018-11-26 |
| French Cohort for the Study of Non-invasive Tests of Liver Lesions in NAFLD/NASH (FreSH Cohort) (NCT03695796) | University Hospital, Angers | 2018-11-22 |
| Dietary Intervention for Low Free Sugars in Children With Non-alcoholic Fatty Liver Disease (NCT06579729) | China Medical University, China | 2018-10-01 |
| Prevalence, Incidence and Characteristics of NAFLD/NASH in Type 1 Diabetes Mellitus (NCT04664036) | University Hospital, Antwerp | 2018-09-17 |
| Use of Shear Wave Elastography to Assess Non-alcoholic Fatty Liver Disease (NAFLD) (NCT03587298) | RWTH Aachen University | 2018-09-15 |
| An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function (NCT03674476) | Bristol-Myers Squibb | 2018-09-11 |
| Impact of a Specific Micronutrient-probiotic-supplement on Fatty Liver of Patients After Mini-Gastric Bypass Surgery (NCT03585413) | Bonn Education Association for Dietetics r.A., Cologne, Germany | 2018-08-31 |
| Effect of Obesity on Proton Pump Inhibitors (NCT04248335) | Children's Mercy Hospital Kansas City | 2018-07-03 |
| Copeptin and Nonalcoholic Fatty Liver Disease (NCT03254563) | University of Colorado, Denver | 2018-06-19 |
| Investigation of Microbiome-based Prognostical Biomarkers in Patients With Morbid Obesity and Bariatric Surgery (NCT03391401) | St. Franziskus Hospital | 2018-03-01 |